On risk and plant-based biopharmaceuticals

Robert K D Peterson, Charles J. Arntzen

Research output: Contribution to journalArticle

59 Scopus citations

Abstract

Research into plant-based expression of pharmaceutical proteins is proceeding at a blistering pace. Indeed, plants expressing pharmaceutical proteins are currently being grown in field environments throughout the USA. But how are these plants and proteins being assessed for environmental risk and how are they being regulated? Here, we examine the applicability of the risk assessment paradigm for assessing human and ecological risks from field-grown transgenic plants that express pharmaceutical proteins.

Original languageEnglish (US)
Pages (from-to)64-66
Number of pages3
JournalTrends in Biotechnology
Volume22
Issue number2
DOIs
StatePublished - Feb 2004

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering

Fingerprint Dive into the research topics of 'On risk and plant-based biopharmaceuticals'. Together they form a unique fingerprint.

  • Cite this